{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011636","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.606277+00:00","generated_at":"2026-06-13T13:49:34.344185+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ProMIS Neurosciences shareholders elect all eight directors, ratify auditor, approve continuance","bullets":["All eight director nominees elected: highest 3.47M for Cashman; lowest 3.05M for Wyman; broker non-votes 914k.","Ratification of Baker Tilly US, LLP as auditor for FY2023: 4.29M votes for, 99.6k against, 1.1k abstain.","Continuance to Ontario approved: 4.54M for, 103.9k against, 6.7k abstain; overall quorum 93.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011636","json":"https://secwatch.observer/filing/0001558370-23-011636.json","markdown":"https://secwatch.observer/filing/0001558370-23-011636.md","text":"https://secwatch.observer/filing/0001558370-23-011636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000155837023011636/0001558370-23-011636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000155837023011636/pmn-20230629x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:49:34.344185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08db9d0c851851888a6c44b24a7b95ea4e44a716","claim":"ProMIS Neurosciences Inc. shareholders approved Election of eight nominees to serve as directors until the 2024 annual meeting of shareholders or until his or her successor has been duly elected and qualified or until his or her earlier resignation or removal. at the 2023-06-29 meeting.","evidence_excerpt":"Proposal No. 1 : Election of eight nominees to serve as directors until the 2024 annual meeting of shareholders or until his or her successor has been duly elected and qualified or until his or her earlier resignation or removal. The votes were cast as follows by holders of Common Shares: ​ ​ ​ ​ Name ​ Votes For ​ Votes Against ​ Abstained Eugene Williams 3,320,369 ​ 147,921 ​ 12,872 Neil Cashman, M.D. 3,470,265 ​ 8,611 ​ 2,286 Gail Farfel, Ph.D. 3,376,107 ​ 103,302 ​ 1,753 Patrick D. Kirwin 3,314,138 ​ 154,640 ​ 12,384 Joshua Mandel-Brehm 3,316,160 ​ 112,636 ​ 52,366 Maggie Shafmaster, Ph.D., JD 3,292,796 ​ 103,924 ​ 84,442 Neil K. Warma 3,266,932 ​ 164,174 ​ 50,056 William Wyman 3,048,981 ​ 382,124 ​ 50.057 ​ ​ Broker Non-Votes: 914,356. All eight nominees were elected.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1374339/000155837023011636/0001558370-23-011636-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-29"}],"fact_type":"shareholder_vote"},{"claim_id":"93e58d6a669ee2f7cb0c3252961ef474c4f8c0b4","claim":"ProMIS Neurosciences Inc. shareholders approved Approval to continue the Company to the jurisdiction of the Province of Ontario under the Business Corporations Act (Ontario). at the 2023-06-29 meeting.","evidence_excerpt":"Proposal No. 3: Approval to continue the Company to the jurisdiction of the Province of Ontario under the Business Corporations Act (Ontario). The votes were cast as follows by holders of Common Shares and Preferred Shares, voting together: ​ ​ ​ ​ ​ ​ ​ Votes For Votes Against Abstained Approval of Continuance into Ontario 4,537,149 ​ 103,948 ​ 6,731 ​ ​ ​ ​","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1374339/000155837023011636/0001558370-23-011636-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-29"}],"fact_type":"shareholder_vote"},{"claim_id":"e5144139a86e2248e2af92071b3c8136e291724c","claim":"ProMIS Neurosciences Inc. shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-29 meeting.","evidence_excerpt":"Proposal No. 2: Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows by holders of Common Shares: ​ ​ ​ ​ ​ ​ ​ ​ Votes For Votes Against Abstained Ratification of appointment of Baker Tilly US, LLP 4,294,824 ​ 99,591 ​ 1,103 ​ ​","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1374339/000155837023011636/0001558370-23-011636-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-29"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}